US FDA Postpones Advisory Panel Meeting On Oral Phenylephrine GRASE
Executive Summary
Change noted without elaboration in update to FDA announcement on Nonprescription Drugs Advisory Committee meeting. CHPA also notes change, saying it’s best for Industry and for consumers.